How should a dry (non‑productive) cough be evaluated and managed?

Evaluation and Management of Dry Cough

For a dry (non-productive) cough, first determine the duration: if less than 3 weeks (acute), treat the underlying viral infection symptomatically; if 3-8 weeks (subacute), consider post-infectious causes; if greater than 8 weeks (chronic), systematically evaluate and treat the most common causes—upper airway cough syndrome (UACS), asthma, and gastroesophageal reflux disease (GERD)—in sequential and additive steps. 1, 2

Initial Assessment by Duration

The duration of cough is the critical first step in narrowing your differential diagnosis 1:

• Acute cough (<3 weeks): Usually viral upper respiratory infection or acute bronchitis
• Subacute cough (3-8 weeks): Most commonly post-infectious; consider transient bronchial hyperresponsiveness, pertussis, or early chronic causes
• Chronic cough (>8 weeks): Requires systematic evaluation for UACS, asthma, non-asthmatic eosinophilic bronchitis (NAEB), and GERD

Red Flags to Address Immediately

Before proceeding with algorithmic management, screen for life-threatening conditions 1:

• Hemoptysis
• Significant dyspnea at rest
• Fever with systemic symptoms suggesting pneumonia
• Suspected pulmonary embolism

If any red flags are present, stop and evaluate these emergently rather than following the chronic cough algorithm.

Chronic Dry Cough: Systematic Evaluation

Step 1: Medication Review and Environmental Assessment

• Discontinue ACE inhibitors if the patient is taking them—this alone resolves cough in many cases 1, 2
• Also consider stopping sitagliptin 1
• Assess for occupational or environmental exposures to irritants 1

Step 2: Initial Diagnostic Testing

Obtain cost-effective baseline studies 3:

• Chest radiograph (to rule out structural disease)
• Spirometry (to assess for reversible airflow obstruction)

Step 3: Sequential Empiric Treatment

The key principle is that multiple causes often coexist, so treatments should be added sequentially rather than abandoned if partially effective 2.

First: Treat for UACS (Post-Nasal Drip)

• Start with a first-generation oral antihistamine/decongestant combination 2
• This addresses rhinosinus conditions causing upper airway irritation
• Continue for 2-4 weeks before assessing response

Second: Evaluate and Treat for Asthma

If cough persists after UACS treatment 2:

• Ideally perform bronchoprovocation challenge if spirometry is normal (histamine challenge has 88% positive predictive value for cough-variant asthma) 4
• If bronchoprovocation unavailable, give empiric trial of inhaled corticosteroids plus bronchodilators or leukotriene inhibitors
• Consider short course of oral corticosteroids if response is unclear

Important caveat: Medical history alone is unreliable for ruling asthma in or out as a cause of dry cough 2.

Third: Consider NAEB

If UACS and asthma treatments fail 2:

• Ideally obtain induced sputum for eosinophil count
• If unavailable, give empiric trial of corticosteroids

Fourth: Treat for GERD

If cough responds only partially or not at all to above interventions 2:

• Note the 2018 update: Acid suppression alone is no longer recommended 1
• Consider 24-hour esophageal pH monitoring if available (negative test effectively rules out GERD as cause) 4
• Treatment should address both acid and non-acid reflux mechanisms

Follow-Up and Monitoring

• Use a validated cough severity tool at baseline and follow-up to objectively assess treatment response 1
• Schedule follow-up within 4-6 weeks after initial evaluation 1
• If cough persists despite systematic treatment, arrange another appointment

Refractory Chronic Cough

When all common causes have been addressed without resolution 1, 3:

• Refer to a recognized cough specialist or pulmonologist
• Consider physiotherapy and speech/language therapy
• Trial of gabapentin or amitriptyline may provide symptomatic relief 3

Practical Considerations

The evidence shows that while ENT examination and sinus CT scans are frequently positive, they have low positive predictive value (63-67%) for UACS actually causing the cough 4. This means upper airway disease often coexists but doesn't always contribute to cough—don't rely on imaging alone to guide treatment decisions.

Similarly, approximately 18% of patients will have no identifiable cause despite comprehensive evaluation 4, so be prepared to manage symptomatically in these cases.

The sequential, additive approach is critical because studies consistently show that more than one condition contributes to chronic cough in many patients 2. Don't stop treatments that provide partial benefit when adding the next intervention.